Strainprint™, the leader in cannabis data collection and strain efficacy reporting, is pleased to announce the launch of its Ambassador Research Program. The Strainprint Ambassador program is available to qualified researchers that use Strainprint’s revolutionary data gathering and analytics tools to conduct observational cannabis studies in relation to specific medical conditions.
Strainprint™ Technologies Ltd. Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community PRESS RELEASE Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest […]
July 22, 2017 – Strainprint was recently featured in High Canada. Our story focused on innovation within the industry.
Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.
PRESS RELEASE – Strainprint TORONTO, April 6, 2017 /CNW/ – Strainprint Technologies Ltd. (“Strainprint™”) — a leader in cannabis patient data collection — is proud to announce the launch of a revolutionary Cannabis Tracking APP & platform. The mobile APP has been created by patients for patients and is now available for both Apple iOS […]